Focus area
Severe Illness: programmes that hold
Severe Illness is an access product: it insures treatment for severe conditions where local care reaches its limits. Three pillars decide whether a programme holds — the reinsurer, the treatment network and the reporting. This page sets out what matters and leads into the articles of the series.
Definition
Severe illness is not critical illness
Severe illness covers the actual treatment costs of defined severe conditions — oncology, major cardiovascular events, complex neurosurgery, transplants. Cover is trigger-based, works with high limits and is usually tied to a treatment network. Systematically it is medical expense insurance.
Critical illness pays a lump sum on diagnosis with no reference to the costs incurred and is a benefit-defined product. The distinction is not a matter of wording: it determines the line of business, the pricing logic, the tax treatment, the reinsurance structure and the distribution route. Confusing the two means pricing the wrong product.
The value of a severe illness programme arises where local treatment capability is insufficient. Without contracted centres all that remains is a promise to pay — the network is not an added service, it is the product itself.
What a programme stands on
The three pillars
Reinsurer
More than capacity: the pricing model, condition definitions, the anti-selection framework and claims expertise. Quota share as the base, per-risk excess of loss for the tail, an aggregate stop-loss in the start-up phase. Back-to-back wording is a precondition, not a negotiating position.
Read it in the articleTreatment network
Depth over breadth: a few centres with proven capability in the covered indication groups, episode pricing rather than fee-for-service, the second opinion as a gate, and reliable payment as the basis of provider trust.
Read it in the articleReporting
A severe illness book is statistically almost invisible in its first two years. Steering runs on leading indicators: incidence per 1,000 lives against the pricing assumption, the notification pipeline, network penetration, cost per episode and the mix of new business.
Read it in the articleWho this page is for
- Reinsurers underwriting a programme who need to assess a credible product and network architecture.
- Carriers and MGAs setting up severe illness in a new market or sharpening an existing programme.
- Distribution partners and employee benefits brokers planning entry through corporate business.
- Ministries, sovereign funds and investors in emerging markets closing care gaps through a programme.
The three articles in context
Articles in the series
Severe Illness programmes: the three load-bearing pillars
What the reinsurer, the treatment network and the reporting must deliver — including the timeline and the eight mistakes that sink programmes.
Read the full articleCost containment in international medical claims
Why effective cost steering happens before the invoice exists: triage, care pathway steering, network contracts and the guarantee of payment.
Read the full articleDACH market entry for foreign personal lines insurers
Authorisation, distribution and operating model: what market entry in the German-speaking region actually requires.
Read the full articleReviewing or building a programme
Considering a severe illness programme for your market? A structured first conversation establishes whether the three pillars hold — and where the gaps in the concept sit.